CanSino Biologics, Inc. Class H (6185) Receives a Buy from UBS

In a report released on June 25, from UBS maintained a Buy rating on CanSino Biologics, Inc. Class H, with a price target of HK$52.40. The comp...

Raccontata damarkets.businessinsider.com